600829.SH
HPGC Renmintongtai Pharmaceutical Corp.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 8.56
−0.58%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.09x
- PEG TTM
- —
- Price / book
- 1.58x
- Price / sales
- 0.46x
- Price / cash flow
- 18.52x
Enterprise value
- Enterprise value
- CNY 4.7B
- EV / sales
- 0.45x
- EV / EBITDA
- 21.52x
- EV / EBIT
- 23.33x
- Market cap
- CNY 5.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026